# US 2023/0405055 A1 · Development of amnion-like tissue from human pluripotent stem cells

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0405055 A1
- Document ID: US20230405055A1
- Status: Published application
- Kind: A1
- Application number: 18/333,705
- Filed: 2023-09-11
- Published: 2023-12-21
- Earliest claimed: 2016-12-09
- Assignees: The Regents of the University of Michigan
- Applicants: The Regents of the University of Michigan
- Inventors: Jianping Fu; Deborah Gumucio; Yue Shao; Kenichiro Taniguchi; Yi Zheng; Sajedeh Nasr Esfahani
- Web page: https://patentgrep.com/patent/US20230405055A1

## CPC

- A61K 35/545: Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
- A61K 31/74: Synthetic polymeric materials
- A61K 35/50: Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
- C12N 5/0068: {General culture methods using substrates (for specific animal cell type C12N5/06)}
- C12N 5/0605: {Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly}
- G01N 33/5044: {involving specific cell types}
- C12N 2502/45: Artificially induced pluripotent stem cells
- C12N 2533/30: Synthetic polymers
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present disclosure provides compositions and methods employing stem cell-derived amnion tissue. In some embodiments, compositions (e.g., scaffolds and devices) and methods of generating amnion-like tissues from hPSCs are provided. In some embodiments, uses of such cells for research, compound screening and analysis, and therapeutics are provided.

## Claims

### Claim 1

A method for preparing amnion-like tissue, comprising: culturing cells on a solid support coated with a gel matrix, wherein said cells are coated with further gel matrix under conditions such that amnion-like tissue is generated.

### Claim 2 (depends on 1)

The method of claim 1, wherein said cells are stem cells.

### Claim 3 (depends on 1)

The method of claim 1, wherein said cells are induced pluripotent cells.

### Claim 4 (depends on 1, 2, 3)

The method of claims 1 to 3, wherein said solid support comprises a plurality of microposts.

### Claim 5 (depends on 2)

The method of claim 2, wherein the stem cells are induced pluripotent stem cells (iPSCs).

### Claim 6 (depends on 5)

The method of claim 5, wherein the iPSCs are human iPSCs.

### Claim 7 (depends on 2)

The method of claim 2, wherein the stem cells are human embryonic stem cells.

### Claim 8 (depends on 1)

The method of claim 1, wherein said surface is glass or PDMS.

### Claim 9 (depends on 1, 2, 3, 4, 5, 6, 7, 8)

The method of claims 1 to 8, wherein said gel matrix is a natural or synthetic polymeric hydrogel.

### Claim 10 (depends on 9)

The method of claim 9, wherein said gel matrix is growth factor basement membrane matrix or Matrigel.

### Claim 11 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10)

The method of claims 1 to 10, wherein said amnion-like cells are an asymmetric cyst.

### Claim 12 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11)

The method of claims 1 to 11, wherein said cells are generated in a device comprising parallel first, second, and third channels wherein said first and second channels are cell channels comprising a loading reservoir operably linked to said third channel comprising a gel interaction matrix.

### Claim 13 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)

A composition comprising a plurality of cells produced by the method of claims 1 to 12.

### Claim 14 (depends on 13)

A method for testing a compound, comprising: a) providing a composition of claim 13; b) exposing a test compound to said composition; and c) determining an effect of said test compound on said composition.
